Literature DB >> 11021890

Minimising harm from hepatitis C virus needs better strategies.

N Crofts, S Caruana, S Bowden, M Kerger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11021890      PMCID： PMC1118695     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.

Authors:  N Crofts; C K Aitken; J M Kaldor
Journal:  Med J Aust       Date:  1999-03-01       Impact factor: 7.738

2.  HIV and hepatitis C among injecting drug users.

Authors:  R A Coutinho
Journal:  BMJ       Date:  1998-08-15

3.  Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995.

Authors:  N Crofts; C K Aitken
Journal:  Med J Aust       Date:  1997-07-07       Impact factor: 7.738

4.  Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

Authors:  I van Beek; R Dwyer; G J Dore; K Luo; J M Kaldor
Journal:  BMJ       Date:  1998-08-15

Review 5.  Occupational health in surgery: risks extend beyond the operating room.

Authors:  J A Patz; D Jodrey
Journal:  Aust N Z J Surg       Date:  1995-09
  5 in total
  9 in total

Review 1.  The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Authors:  Michelle Gillies; Norah Palmateer; Sharon Hutchinson; Syed Ahmed; Avril Taylor; David Goldberg
Journal:  BMC Public Health       Date:  2010-11-23       Impact factor: 3.295

2.  Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Authors:  C Matheï; E Wollants; J Verbeeck; M Van Ranst; G Robaeys; P Van Damme; F Buntinx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  Reducing HIV-related risk behaviors among injection drug users in residential detoxification.

Authors:  Robert E Booth; Barbara K Campbell; Susan K Mikulich-Gilbertson; Carrie J Tillotson; Dongseok Choi; James Robinson; Donald A Calsyn; Raul N Mandler; Lindsay M Jenkins; Laetitia L Thompson; Catherine L Dempsey; Michael R Liepman; Dennis McCarty
Journal:  AIDS Behav       Date:  2011-01

4.  Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.

Authors:  P De; E Roy; J-F Boivin; J Cox; C Morissette
Journal:  J Viral Hepat       Date:  2008-01-20       Impact factor: 3.728

5.  Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran.

Authors:  Nazila Kassaian; Peyman Adibi; Alireza Kafashaian; Majid Yaran; Zary Nokhodian; Parisa Shoaei; Razieh Hassannejad; Anahita Babak; Behrooz Ataei
Journal:  Int J Prev Med       Date:  2012-03

6.  Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study.

Authors:  Mohsen Vazirian; Bijan Nassirimanesh; Saman Zamani; Masako Ono-Kihara; Masahiro Kihara; Shahrzad Mortazavi Ravari; Mohammad Mehdi Gouya
Journal:  Harm Reduct J       Date:  2005-10-07

7.  Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.

Authors:  Mark A Stoové; Craig L Fry; Nicholas Lintzeris
Journal:  Harm Reduct J       Date:  2008-04-23

8.  Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.

Authors:  Tyler S Bartholomew; Jason Onugha; Corinne Bullock; Carolina Scaramutti; Hardik Patel; David W Forrest; Daniel J Feaster; Hansel E Tookes
Journal:  Harm Reduct J       Date:  2020-06-10

9.  Seroprevalence of hepatitis B markers among incarcerated intravenous drug users.

Authors:  Zary Nokhodian; Majid Yaran; Peyman Adibi; Nazila Kassaian; Marjan Meshkati; Behrooz Ataei
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.